PT - JOURNAL ARTICLE AU - Zhang, Xinhe AU - Grove, Jakob AU - Gu, Yuanjun AU - Buus, Cornelia K AU - Nielsen, Lea K AU - Neufeld, Sharon A.S. AU - Koko, Mahmoud AU - Malawsky, Daniel S AU - Wade, Emma AU - Verhoef, Ellen AU - Gui, Anna AU - Hegemann, Laura AU - , AU - , AU - , AU - Geschwind, Daniel H AU - Wray, Naomi AU - Havdahl, Alexandra AU - Ronald, Angelica AU - St Pourcain, Beate AU - Robinson, Elise B AU - Bourgeron, Thomas AU - Baron-Cohen, Simon AU - Borglum, Anders D AU - Martin, Hilary C AU - Warrier, Varun TI - An axis of genetic heterogeneity in autism is indexed by age at diagnosis and is associated with varying developmental and mental health profiles AID - 10.1101/2024.07.31.24311279 DP - 2024 Jan 01 TA - medRxiv PG - 2024.07.31.24311279 4099 - http://medrxiv.org/content/early/2024/08/02/2024.07.31.24311279.short 4100 - http://medrxiv.org/content/early/2024/08/02/2024.07.31.24311279.full AB - There is growing recognition that earliest signs of autism need not clearly manifest in the first three years of life. To what extent is this variation in developmental trajectories associated with age at autism diagnosis? Does the genetic profile of autism vary with age at autism diagnosis? Using longitudinal data from four birth cohorts, we demonstrate that two different trajectories of socio-emotional behaviours are associated with age at diagnosis. We further demonstrate that the age at autism diagnosis is partly heritable (h2SNP = 0.12, s.e.m = 0.01), and is associated with two moderately correlated (rg = 0.38, s.e.m = 0.07) autism polygenic factors. One of these factors is associated with earlier diagnosis of autism, lower social and communication abilities in early childhood. The second factor is associated with later autism diagnosis, increased socio-emotional difficulties in adolescence, and has moderate to high positive genetic correlations with Attention-Deficit/Hyperactivity Disorder, mental health conditions, and trauma. Overall, our research identifies an axis of heterogeneity in autism, indexed by age at diagnosis, which partly explains heterogeneity in autism and the profiles of co-occurring neurodevelopmental and mental health profiles. Our findings have important implications for how we conceptualise autism and provide one model to explain some of the diversity within autism.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was supported by funding from the Simons Foundation for Autism Research Initiative, the Wellcome Trust (214322\Z\18\Z)，Horizon-Europe R2D2-MH (grant agreement number 101057385), and UKRI (10063472). For the purpose of open access， we have applied a CC BY public copyright licence to any author-accepted manuscript version arising from this submission. S.B.-C. also received funding from the Autism Centre of Excellence at Cambridge, the Templeton World Charitable Fund, the MRC and the National Institute for Health Research Cambridge Biomedical Research Centre. The research was supported by the National Institute for Health Research Applied Research Collaboration East of England. Any views expressed are those of the author(s) and not necessarily those of the funder. Some of the results leading to this publication have received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement no.777394 for the project AIMS-2-TRIALS. This joint undertaking receives support from the European Union's Horizon 2020 research and innovation program and the EFPIA and Autism Speaks, Autistica and the SFARI. The iPSYCH team was supported by grants from the Lundbeck Foundation (R102-A9118,R155-2014-1724 and R248-2017-2003), the NIMH (1R01MH124851-01 to A.D.B.), and EU's Horizon Europe program (R2D2-MH; grant agreement no. 101057385 to A.D.B.). The Danish National Biobank resource was supported by the Novo Nordisk Foundation. High-performance computer capacity for handling and statistical analysis of iPSYCH data on the GenomeDK HPC facility was provided by the Center for Genomics and Personalized Medicine and the Centre for Integrative Sequencing, iSEQ, Aarhus University, Denmark (grant to A.D.B.). The UK Medical Research Council and Wellcome (Grant ref: 217065/Z/19/Z) and the University of Bristol provide core support for ALSPAC. This publication is the work of the authors and the authors will serve as guarantors for the contents of this paper. A comprehensive list of grants funding is available on the ALSPAC website (http://www.bristol.ac.uk/alspac/external/documents/grant-acknowledgements.pdf). R2D2-MH has been funded by Horizon Europe [grant agreement no. 101057385], by UK Research and Innovation (UKRI) under the UK government's Horizon Europe funding guarantee [grant no.10039383] and by the Swiss State Secretariat for Education, Research and Innovation (SERI) under contract number 22.00277.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All data we used in the study were from existing datasets. The Cambridge Human Biology Research Ethics Committee gave ethical approval to analyse de-identified data for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesSPARK autism GWAS: https://bitbucket.org/steinlabunc/spark_asd_sumstats/src Finngen autism GWAS: https://www.finngen.fi/en/access_results iPSYCH autism GWAS (unstratified, sex-stratified and age at diagnosis stratified) can be obtained from Anders Borglum and Jakob Grove. Psychiatric GWAS summary stats: https://pgc.unc.edu/ GWAS educational attainment: https://thessgac.com/ GWAS cognitive aptitude: https://cncr.nl/research/summary_statistics/ For ALSPAC, the study website contains details of all the data that is available through a fully searchable data dictionary and variable search tool": http://www.bristol.ac.uk/alspac/researchers/our-data/ For MCS, data can be obtain after application through the UK Data Service: https://beta.ukdataservice.ac.uk/datacatalogue/series/series?id=2000031 Summary statistics for the SPARK based GWAS will be made upon publication.https://bitbucket.org/steinlabunc/spark_asd_sumstats/srchttps://www.finngen.fi/en/access_resultshttps://pgc.unc.edu/https://thessgac.com/https://cncr.nl/research/summary_statistics/http://www.bristol.ac.uk/alspac/researchers/our-data/https://beta.ukdataservice.ac.uk/datacatalogue/series/series?id=2000031